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THERE are many reported examples of animals having been rendered immune
or resistant, by various procedures, to subsequent inoculations of a tumour to
which they are normally susceptible. The attenuation of tumourfragments by
irradiation before implantation will, on occasion, produce antigenic changes in
thetumoursufficientto induce immunity. Goldfeder (1942) first pointedoutthe
quantitative relationship between the attenuation dose and the immunising pro-
perty oftheimplant, in this case Sarcoma 180. With anadequately inbred strain
Eke the C3H mouse, however, andusinghomologous mammary tumour which has
not lost its genetic specificity by repeated serial transplantation, absolute resis-
tance to further implants of the same tumour cannot be evoked.
It was previously shown that the radiosensitivity of a homologously-trans-
mitted tumour is a function ofthe state ofresistance ofthe host. When the resist-
ance of a tumour-bearing C3H mouse is impaired by total body irradiation, the
effective dose for treatment of the tumour increases; and, conversely, when some
degree of resistance in a host arises from a relative genetic incompatibihty of the
host-tumo-Lir relationship, as in the case of hybrids bearing the parent strain
tumour, the required dose is significantly decreased (Oughterson, Tennant and
Lawrence, 1940). In this respect, estimation of an induced increase in radiosen-
sitivity may be a sensitive indicator of subhminal host resistance when other
criteria are lacking.
The significance of this concept was emphasised when
" takes
" arising from
tumour fragments irradiated prior to implantation in the course of a previous
experiment (Cohen and Cohen, 1953a) were subsequently treated and found to
have a significantly increased radiosensitivity. It seemed probable that this
change in radiosensitivity was a result of a minor degree of induced resistance
in these animals, and a further investigation- was undertaken to elucidate the
respective ro'les of the host and the tumour in this phenomerion.
EXIFERIMENT 1.
Materials and methods.
This preliminary investigation was based on 51 mice which had been inocu-
lated with tumour fragments, irradiated in a plastic welled slide immediately
before implanatation with doses of 2000 or 2500 r, as described in our first com-
munication (Cohen and Cohen, 1953a). Practically all-implants attenuated at90
70
so
5
40
30
20
10
0 1
I.
i
.10.
G0000""
I
q.p
1,00000,
a
I /
F I
I I
I I
I
I
I
I
-%A-r, 0 %,
..o 4
r. 2 0 . Q
S. I e
E
j
E
p
314 A. COHEN AND L. COHEN
these sublethal doses
" took,
.7after a more or less prolonged latent period averag-
ing 30 days, and then grew progressively at the normal growth rate. When the
tumours hadreachedthe standard size ofabout I cm. in thelargest diameter (over-
all average volume 250 4- 81 mm.3), thev were irradiated in situ with our stan-
dardised techni.qu'e as previously reported in detail. All mice were individually
numbered and examined atregular intervals for at least 3 months after treatment.
With the doses used in this series, the tumoiir has, within this observation period,
either disappeared completely or bas resumed active growth, ulcerating the skin
and killing the mouse by exsanguination or infection.
Inorder to detectanyacquiredincreaseinradiosensitivity, tumoursarisingfrom
each attenuation-dosage group were treated at three dose levels: 3500, 4200 and
5000 r, making a total of six categories tested. Since the probability ofcuring an
unattenuated C3H tumour in the con-trol series with 4200 r is less than 0-1 per
cent, even a few cures at this dose in an experimental series would be significant.
The propoi-tion of c-Lires obtained at each level was tabulated and analysed by the
probit method, estimating the median effective dose (LD50)
, theslope andlinearity
oftheregressionline, and themagnitude andsignificance ofthe difference between
these results and the previously estabhshed parameters fbr the control series.
Results.
The proportion of cures obtained in each of the six experimental categories is
shown in Table I. It is fairly obvious, and readfly confirmed by analysis of the
data, that for anygiven dose in situ there is no significant difference between the
response of tumours attenuated at 2000 r and at 2500 r. Accordingly, thepooled
.results from both attenuation groups, given various doses in situ, are shown
Table I and plotted in Fig I (Line G) where they may be compared with the
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FIG. I.-Probit diagram showing response to treatment at various doses ofhomoplasts of the
C3H carcinoma attenuated before iinplantation (Line G), compared with previously estab-
lished data for the unattenuated tumour (Line A). Also shown are the proportion of cures
when attenuated homoplasts are transplanted to other animals (Points H, J) ; transplanted to another site in the donor mice (Point I); or recurrent in the site ofsurgical excision (Point Ki.315 RADIO-SENSITIVITY OF ATTENUATED HOMOPLASTS
control series (Line A). It will be noted that the probit regression line in the
attenuated series differs both in position and slope from that ofthe controls.
The LD, for the attenuated homoplasts is found to be 4500 (± 200*) r,
compared with 5700 r previously determined in the controls, and the coefficient
of variation is 26 per cent compared to 9 per cent in the controls. The relative
radiosensitivity of attenuated tumours with reference to the controls, that is the
ratio of theLD50's is 5700
. 1-27 (± 0-07*). Since this ratio exceeds unit by 4500 y
four times its standard error, the result is highlysignificant (p < 0-0001), indicat-
ing a definite acquired radiosensitivity of the tumour arising from an attenuated
implant.
As has been previously shown, a changed radiosensitivity generally reflects
anunderlyingchange in host-resistance to the tumour. It would appear,therefore.,
that the attenuation procedure, while not producing any absolute immunity to
further implants of the same tumour, nevertheless induces within the host, albeit
the strain oforigin ofthe tumour, a subliminal resistant state. The increasedslope
of the regression line compared with the coDtrol series cannot be explained by
sporadic fluctuations in cure-rates, but imphes a significant individual variation,
presumablyreflecting someirregular reaction or an inconstantdegree ofresistance
arising in the OH host in response to attenuated tumour fragments.
TABLEL-Response to Treatment in situ ofHomoplasts (OH Mammary Tumour)
Attenuated by Irradiation Pri-or to Implantation.
Attenuation dose.
2000 r 2500 r
A -IN t A
Number Number Number Number Total Cures
Dose in 8itU (r). of mice cured. of mice. cured. cures. (per cent).
5000 5 3 13 8 11/18 61
4200 12 7 7 3 10/19 52
3500 6 0 8 0 0/14 0
EXPERIMENT 2.
For the purpose of discerning whether the acquired radiosensitivity of at-
tenuated homoplasts was (a) a persistent measurable change in the attenuated
" take," (b) a local effect at the site of implantation or, (c) a manffestation of
systemic resistance in the host, a second experiment was done.
Materials and methods.
Us' the same mouse strain and tumours as in the firstexperiment, the follow-
ing procedure was adopted. Tumourfragmenta were irradiated in the plastic shde
describedpreviouslywith doses of2000 r, and then inoculatedsubcutaneously into
theright flanks of 11 mice.Although the latentperiod was increased to an average
of 27 days, the growth rates ofthe estabhshed tumours were not less than that of
unirradiatedimplants. Eachtumourwasallowedtogrowto adiameter ofapproxi-
mately I cm., and then excised with a sterfle surgical technique and fragments
* Standard errors of median and of ratios ofmedians.316 A. COHEN AND L. COHEN
re-inoculated into the left flank of the tumour-bearer, an-cl, -at the same time into
2 other mice (recipients). Allinoculations
" took
" (reverting tothe normallatent
interval), and there were also recurrences in 7 ofthe II surgical donor sites, giving
40 tumours in all.
Using the irradiation procedure previously described, all
" donors
" were
treated with 4200 r in situ, bilaterally where necessary. Of the 22
" recipients
"
(2 to each donor), 11 were similarly treated in situ with 4200 r in order to detect
persistent acquiredradiosensitivity in the tumour transplants, and the remaining
II were treated with 7500 r in8itUto exclude thepossibiHty of an acquired radio-
resistance. The former dose will result in practically no cures of unattenuated
C3H mammary tumour homoplasts, so that even a few cures in the first group
woul(i be statistically significant; while with the latter dose the pr'obability of
cure exceeds 99-8 per cent, so that a few failures would indicate a significant
acquired radioresistance.
Results.
At the be of this series of treatments, an immediate radiation mor-
-tality was noted in donors in which bilateral tumours had been treated on the
same day. Since a follow-up of about 3 months after treatment is essential for
evaluating cures, it was subsequently attempted to
i 'Mise the lethal effect by
niore carefulsurgical eradication ofthe original tumour, thus obviating the neces-
sity for bilateral irradiation, and allowing a period of recovery of at least a week
between treatments when bilateral tumours still occurred. The added disad-
vantage of bilateral treatments, even when the immediate mortahty could be
reduced, was thepossibilitythat the increasedbody dose would lower theexpected
percentage of cures, as previously demonstrated (Cohen and Cohen, 1953b). The
results of' treatment of the attenuated homoplasts in the four experimental
categories are shown in Table II, and the proportion of cures in each group
plotted in Fig. I for comparison witb- tlle other relevant data.
TABLEII.-Response to Treatment in sit'u of Attenuated Homopla8ts after Excision
and Transplantation.
Normally Symbol Dose in Number Number Cures expected (Fig. 1). 8itU (r). of mice. cured. (percent). cure rate
Donors: (per cent). Recurrent in site of ex-
cision K 4200 7 0 0
Transplanted in oppo- 0.1 site side . I 4200 11 4 37
Recipients I H 4200 11 0 0
Recipients II 7500 11 11 100 99- 8
Inspite ofthe adverse effects ofbilateral irradiation, it can'be seen in Table II
that asignificant proportion of cures (37 per cent) did eventuate in the case ofthe
re-inoculatedtumoursinthedonors treated with 4200 r. FromFig. 1 it canbe seen
that theproportion of cures to beexpecied at thisdosage with unattenuated homo-
plasts (Line A) is exceedingly small, while in animals bearing attenuatedimplants (Line G) it is 40 per cent, from which this result. (Point I) does not differ appre- ciably. On the other hand, the combination of body dose and damaae of the
vascular stroma bv sur-aery may be consideredresponsible for the sharp reductionRADIOSENSITIVITY OF ATTENUATED ROMOPLASTS 317
in cure-rate of the tumour recurrences in the excision sites (0/7 cures), even where
increasedradiosensitivity of the tumour on the' other side existed. These findings
eliminate the possibility that the increasedradiosensitivity is due to a local resist-
ancearisingduring thesojoum ofthe attenuatedhomoplast at theoriginalimplan-
tation site, but indicate the existence of a generalised or systemic change.
Reference to Table 11 also shows that, when the attenuated "take
" was trans-
planted to otherrecipients, the resultant tumours were neither more radiosensitive
(O/II cures at 4200r), nor less radiosensitive (II/II cures at 7500r) than the unat-
tenuated control homoplast in the C3H mouse (Cohen and Cohen, 1953a). In
this connection it is interesting to note that, although the original tumour frag-
ments attenuated with 2000 rprior toimplantation exhibited theprolonged latent
interval of 27 days, the laten-t period of the subsequent transplants of these
" takes," both in the donors and in the new recipients, was the same as un-
attenuated tumour (7 to 15 days)-. These observations indicate that, in so far as
its growth rate aiid radiosensitivity in new hosts are concerned, the previously
attenuated homoplast has apparently recovered to a large extent from the initial
irradiation.
DISCUSSION.
The most significant finding in these experiments is that some degree ofresist-
ance arises in a proportion of C3H mice as a result of the inoculation of a viable
niammary tumour fragment, attenuated with a known sublethal dose of X-rays
prior to implantation. Aside from the prolonged latent period before such an
attenuated implant becomes palpable (Goldfeder, 1947), no other gross evidence
of alteration as a result of such a procedure has ever been previouslyreported for
this type of host and tumour. This subliminal resistance, or change in the host-
tumour relationship, is manifested by an increase in the radiosensitivity of the
attenuated
" take." It is of interest to note that the response of radiation-
attenuatedhomoplasts in the C3H mouse closely resembles, both in themagnitude
of the effective dose and in the individual variance, that of unattenuated C3H
tumourgrowing infactor-harbouring (C3H x CBA)F,hybrids (Cohen and Cohen,
1954). The attenuation procedure, therefore, seems to induce a degree of resist-
ance, presumably a similar antigenic difference between host and tumotir, at least
as great as that engendered by the tumour growing in F, Ilybrids harbouring the
milk factor.
The following facts conceming the nature of this phenomenon have been
elucidated :
(1) While not excluding the possibiHty that the tumour cells have been
inherentlychangedby thisprocedure, it is obvious that any suchchange is not, in
itself" sufficient to affect the radiosensitivity of the transplanted attenuated
" takes
" in the environment of a new host. Conversely, there is no evidence of
acqiiired radioresistance in the tumour as a result of previous irradiation, in
conformity with Montgomery and Warren's findings (1953).
(2) It is unlikely that any local change in the tumour bed contributes to the
changed radiosensitivity since no cures were obtained when recurrences followina
the local excision at the original site were treated. It can probably be assumed,
too, that damage to the tumour bed by the rsurgical excision was sufficient to
abrogate the effect ofsystemic resistance.
(3) Since the increased radiosensitivity persists even where the tumour has318 A. COHEN AND L. COHEN
been transplanted to another site in the original donor, it must be concluded that
the effect is due to a systemic, generalised resistance mecbanism.
The phenomenon of induced resistance to experimentalfy transmitted. cancer
has been extensively investigated. In the past, results in this field were often
contradictory and confusing (Woglom, 1929), due to the use of heterogeneous
strains of animals and gentically alien tumours. Under these circumstances,
absoluteimmunity to tumours can bereadily inducedby avariety ofexperimental
procedures. There are also reported instances of absolute immunity to a trans-
planted tumour being induced in the strain of origin, even where the animals are
genetically homogeneous (Gross, 1943 ; Goldfeder, 1945 ; Lewis and Aptekman,
1952. Foley, 1952). In each of these reports, however, the tumour had been
repeatedly subpassaged for many generations before its immunising ability was
tested. The long transplantation history of these and other commonly used
tumours, maintained solely by serial transmission, is surveyed by Dunham and
Stewart (1953). It is generally realised that such procedures may perrnit anti-
genic diversification or mutation in the tumour, which, in effect, results in a
relatively unstable host-tumour relationship. Consequently, many of these find-
ings arelargely invalidated in so far as theirapplicability to human cancertherapy
is concemed.
It would appear thatonly when asupply ofspontaneous tumours is constantly
availdble within a given strain, and is routinely transplanted through no more
than a few subpassages to experimental animals of the same strain, can the host-
tuniour relationship be considered adequately stabilised. Where such stringent
conditions prevail, absolute immunity to a tumour cannot be evoked (Bittner,
1936 ; Barrett, 1940 ; Lewis, 1940 ; Fardon and Prince, 1953 ; Foley, 1953). A
recent review by Hauschka (1952) contains an extensive analysis of the immuno-
genetic complexities of host-tumour relationships used in experimental cancer
reseal-ch.
With respect to the CM mammary carcinoma, the authors have shown that,
even where some degree ofimmunogenetic difference existed between the tumour
and the host, as in the case ofF, hybrids bearing the parent strain tumour, no
overt-immunitycouldbeelicitedbycuringthecomparativelyradiosensitivetumour
in8itU (Coben and Coben, 1954), or by previouslv inoculating the animals with
radiation-attenuated fragments (unpubhshed data).
When one correlates these facts with the findings oftheforegoing experiment,
it become's evident that resistance to tumour is by no means an
" all-or-none
"
pbenomenon. It seemslikelythatpartial or subliminal states ofresistance can be
induced in the stable host-tumour relationship which, while not obviously detect-
able by conventional methods, nevertheless yieldsignificant results in the form of
a perceptible increase in radiosensivity.
In this connection, it is significant that Gorer (1947) demonstrated high titres
of circulating anti-tumour iso-antibodies in mice dying of foreign strain tumour
transplants, which grew progressively in spite of antigenic differences with the
hosts. This form of apparently ineffective resistance may be identical with that
responsible for the enhanced response to radiotherapy, from which one might postulate that iso-antibodies may be ehcited by the attenuation procedure even
where obvious genetic differences between host and tumour do not exist. It is
suggested that an efficient wethod of rendering homologoiis tumour a'ntigenic to
its host would have a potent radiosensitizing effect.RADIO-SENSiTIVITY OF ATTENUATED HOMOPLASTS 319
SUMMIARY.
C3H mice bearing homoplasts of the C3H mammary adeno-carcinoma, which
hlad been attenuated prior to implantation with 2000 r and 2500 r, were treated in
situ. The LD50 of these tumours was found to be 4500 (± 200) r, which is signifi-
cantly lower than that of unattenuated homoplasts (5700 r).
The increased radiosensitivity was not a local phenomenon, but persisted in
the original hosts even where the established attenuated homoplast was excised
and transplanted to another site. When the previously attenuated homoplasts
were transplanted from the original hosts to new hosts, however, the curative dose
reverted to that of unattenuated tumour.
It is considered probable that the inoculation of a viable tumour fragment,
attenuated by sublethal doses of radiation prior to implantation, induces a state
of subliminal resistance in the host which enhances the radiosensitivity of the
resultant tumour.
Facilities for the maintenance of our experimental animals were generously
provided at the South African Institute for Medical Research by Dr. J. F. Murray,
to whom we are deeply indebted.
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